Checkpoint inhibitor rechallenge in advanced endometrial cancer: revisiting the immune landscape beyond first-line therapy.

Saved in:
Bibliographic Details
Title: Checkpoint inhibitor rechallenge in advanced endometrial cancer: revisiting the immune landscape beyond first-line therapy.
Authors: Podder V; Mount Sinai Medical Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Miami Beach, FL, USA. Electronic address: drvivekpodder@gmail.com., Coleman RL; Texas Oncology, Gynecologic Oncology, The Woodlands, TX, USA. Electronic address: rcoleman@gog.org., Eskander RN; University of California, San Diego, Rebecca and John Moores Cancer Center, Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, San Diego, CA, USA. Electronic address: reskander@health.ucsd.edu., Flint M; Mount Sinai Medical Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Miami Beach, FL, USA. Electronic address: michelle.flint@msmc.com., Monk BJ; Florida Cancer Specialists and Research Institute, Division of Gynecologic Oncology, West Palm Beach, FL, USA. Electronic address: bmonk@gog.org., Slomovitz BM; Mount Sinai Medical Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Miami Beach, FL, USA. Electronic address: brian.slomovitz@msmc.com.
Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2025 Nov; Vol. 35 (11), pp. 102124. Date of Electronic Publication: 2025 Aug 27.
Publication Type: Journal Article; Review
Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first